Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI

Table 1

Baseline characteristics.

Baseline Characteristics	Impella CP (n = 27)	VA-ECMO (n = 14)	-value
Male	20 (74.1%)	13 (92.9%)	0.15
Median age (years)	73 (50–88 ± 9.7)	69 (53–83 ± 8.8)	0.44
Prior CAD	10 (37%)	8 (57.1%)	0.22
CABG	3 (11.1%)	5 (35.7%)	0.06
Diabetes	9 (33.2%)	3 (21.4%)	0.43
History of smoking	11 (37.0%)	4 (28.6%)	0.44
Hypercholesterolemia	11 (40.7%)	4 (28.6%)	0.44
Hypertension	16 (59.3%)	8 (57.1%)	0.90
Prior malignant disease	2 (7.4%)	0 (0%)	0.30
Peripheral artery disease	6 (22.2%)	6 (42.8%)	0.17
Impaired renal function (eGFR <60, stage ≥3)	10 (37.0%)	3 (21.4%)	0.31
LVEF > 55%	2 (7.4%)	0 (0%)	0.30
LVEF 45–55%	0 (0%)	1 (7.1%)	0.16
LVEF 35–45%	6 (22.2%)	3 (21.4%)	0.95
LVEF < 35%	19 (70.4%)	10 (71.4%)	0.94

CABG = coronary artery bypass graft; CAD = coronary artery disease; LVEF = Left ventricular ejection fraction.